Yuji Kashiwakura Selected Research

Yuji Kashiwakura Research Topics

Disease

11	Neoplasms (Cancer) 07/2012 - 06/2005
8	Hemophilia A (Haemophilia) 05/2013 - 01/2006
4	Hemorrhage 05/2013 - 08/2008
3	Infections 09/2021 - 01/2005
3	Prostatic Neoplasms (Prostate Cancer) 10/2008 - 06/2005
2	Hemophilia B (Haemophilia B) 03/2013 - 06/2010
2	Sepsis (Septicemia) 04/2011 - 01/2006
2	Disseminated Intravascular Coagulation 04/2011 - 01/2006
1	Hypersensitivity (Allergy) 05/2014
1	Disease Susceptibility (Diathesis) 05/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2012
1	Inflammation (Inflammations) 09/2011
1	Anemia 09/2011
1	Bacterial Infections (Bacterial Infection) 09/2011
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2010
1	Brain Infarction 12/2008
1	Ischemia 12/2008
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2008
1	Rare Diseases (Rare Disease) 03/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2007
1	Acute Kidney Injury (Acute Renal Failure) 01/2006
1	Thrombotic Thrombocytopenic Purpura 01/2006
1	Renal Insufficiency (Renal Failure) 01/2006
1	Vascular Diseases (Vascular Disease) 11/2004
1	Atherosclerosis 11/2004
1	Thromboembolism 04/2004
1	Vascular System Injuries 02/2002
1	Hyperplasia 02/2002

Drug/Important Bio-Agent (IBA)

4	Factor VIII (Coagulation Factor VIII)IBA 05/2013 - 01/2006
4	Proteins (Proteins, Gene)FDA Link 08/2011 - 06/2005
3	Blood Coagulation Factors (Coagulation Factor)IBA 03/2013 - 08/2008
2	Neutralizing AntibodiesIBA 09/2021 - 08/2008
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2013 - 06/2010
2	tumor-associated transplantation antigen (TSTA)IBA 07/2012 - 10/2011
2	LuciferasesIBA 07/2012 - 10/2011
2	Leukocyte Elastase (Neutrophil Elastase)IBA 09/2011 - 04/2011
2	FibrinIBA 04/2011 - 04/2004
2	Dacarbazine (DIC)FDA LinkGeneric 04/2011 - 01/2006
2	AntigensIBA 08/2008 - 07/2006
1	nanolucIBA 09/2021
1	Interleukin-5 (Interleukin 5)IBA 05/2014
1	Factor VII (Proconvertin)IBA 05/2013
1	Blood Proteins (Serum Proteins)IBA 03/2013
1	Green Fluorescent ProteinsIBA 07/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2011
1	Dyneins (Dynein)IBA 08/2011
1	Fibrin Fibrinogen Degradation ProductsIBA 04/2011
1	Fibrinolysin FDA Link 04/2011
1	VinculinIBA 10/2010
1	Small Interfering RNA (siRNA)IBA 10/2010
1	Interleukin-7 (Interleukin 7)IBA 05/2009
1	Therapeutic UsesIBA 05/2009
1	InterleukinsIBA 05/2009
1	JTE 013IBA 12/2008
1	Chemotactic FactorsIBA 12/2008
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2008
1	Amino Acids FDA Link 10/2008
1	PolymersIBA 10/2008
1	Phosphotransferases (Kinase)IBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008
1	Factor VIIa (Activated Factor VII)IBA 08/2008
1	Thrombin FDA Link 08/2008
1	Hemostatics (Antihemorrhagics)IBA 08/2008
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2007
1	JNK Mitogen-Activated Protein KinasesIBA 07/2007
1	ADAMTS13 ProteinIBA 01/2006
1	AutoantibodiesIBA 01/2006
1	CreatinineIBA 01/2006
1	Peptide Hydrolases (Proteases)FDA Link 01/2006
1	thiamine triphosphorate (TTP)IBA 01/2006
1	Actins (F Actin)IBA 01/2006
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2006
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 06/2005
1	SERPIN-B5 (maspin)IBA 06/2005
1	integrin alphaVbeta5IBA 01/2005
1	Proto-Oncogene Proteins c-metIBA 01/2005
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2005
1	Dynamin IIIBA 11/2004
1	oxidized low density lipoproteinIBA 11/2004
1	CollagenIBA 02/2002

Therapy/Procedure

4	Therapeutics 03/2013 - 08/2008
3	Transplantation 10/2010 - 07/2006
1	Heterologous Transplantation (Xenotransplantation) 06/2012
1	Injections 10/2008
1	Intramuscular Injections 01/2006
1	Intravenous Injections 01/2006
1	Aftercare (After-Treatment) 06/2005